An Integrative Case Review of Microplastic Burden, Environmental Assessment, and Physiological Restoration

Abstract

Microplastics have emerged as pervasive environmental contaminants, with growing evidence demonstrating their presence in human blood, brain, tissues, and the gastrointestinal tract. Although their contribution to chronic disease remains incompletely understood, experimental and observational studies suggest potential associations with oxidative stress, immune dysregulation, intestinal barrier dysfunction, and chronic inflammation. This clinician-focused case review describes a 61-year-old woman with inflammatory bowel disease (IBD) who presented with an unexpectedly elevated salivary microplastic burden despite maintaining a health-conscious lifestyle. A comprehensive intervention emphasizing environmental exposure mitigation, restoration of gastrointestinal integrity, nutritional optimization, and support of endogenous physiological resilience was implemented. Repeat testing demonstrated a reduction in measured salivary microplastic particle counts from 29 to 12 (−58.6%), accompanied by improvements in gastrointestinal symptoms, fatigue, cognitive clarity, and inflammatory bowel disease activity. Although causal relationships cannot be established from a single patient, this case illustrates a practical framework for clinicians centered on objective assessment rather than assumption. The principal message is straightforward: Test. Mitigate. Restore. Measure.

Introduction

Medicine has always evolved by asking better questions.

For decades, clinicians have recognized that heavy metals, pesticides, endocrine-disrupting chemicals, persistent organic pollutants, and airborne pollutants may influence human health. More recently, attention has turned toward microplastics and nanoplastics—microscopic plastic particles generated through the degradation of larger plastic materials or manufactured for commercial applications. These particles are now detected in drinking water, food, indoor air, textiles, household dust, and numerous consumer products, making human exposure an increasingly common feature of modern life.

Recent investigations have identified microplastic particles in human blood, placental tissue, lung tissue, brain, liver, kidney, breast milk, and atherosclerotic plaque. While these findings confirm that human exposure occurs and that at least some particles can enter biological systems, the clinical implications remain an active area of investigation. Experimental studies suggest that microplastics may influence oxidative stress, inflammatory signaling, epithelial barrier integrity, and immune function, yet standardized methods for clinical testing, reference ranges, and definitive causal relationships with chronic disease have not been established.

Consequently, clinicians are faced with a familiar challenge: How should emerging science influence present-day patient care?

Rather than viewing microplastics as an isolated toxicological concern, they may be more appropriately considered within the broader concept of the human exposome—the cumulative environmental influences encountered throughout life that interact with genetics, nutrition, lifestyle, and physiology. From this perspective, microplastics represent one of many environmental factors that may contribute to an individual’s overall biological burden. For patients with chronic inflammatory disorders, impaired gastrointestinal barrier function, or other conditions affecting physiological resilience, thoughtful assessment of environmental exposures may provide additional clinical insight.

The purpose of this case review is not to establish that microplastics caused disease or that reducing measured particle burden alone explains clinical improvement. Rather, it illustrates a practical approach to environmental medicine in which objective assessment, comprehensive exposure investigation, environmental mitigation, restoration of gastrointestinal physiology, and longitudinal follow-up are integrated into individualized patient care.

Ultimately, this report is intended to encourage clinicians to move beyond assumptions and toward evidence-informed investigation. As environmental exposures become increasingly complex, the challenge is not simply to identify potential toxicants, but to understand how thoughtful assessment, practical mitigation strategies, and support of normal physiology may help patients build greater resilience.

The Patient Story

“I thought I was doing everything right. How could this happen?”

That simple question became the catalyst for a much broader clinical investigation.

A 61-year-old woman, a physician, with a longstanding history of inflammatory bowel disease (IBD), intermittent gastrointestinal symptoms, chronic fatigue, and reduced cognitive clarity presented after receiving an unexpectedly elevated salivary microplastic screening result at the 2025 A4M World Congress in Las Vegas via RSLabs.health. The finding surprised both the patient and her healthcare team. She had followed a health-conscious lifestyle for many years, consumed a predominantly whole-food diet, exercised regularly, minimized unnecessary medications, and actively participated in integrative healthcare. From a traditional clinical perspective, she appeared to represent a relatively low-risk individual for excessive environmental exposure.

Rather than dismissing the result or assuming it represented laboratory variation, we elected to investigate further.

The objective was not to prove that microplastics caused her symptoms, but to determine whether modifiable environmental exposures could be identified and whether reducing those exposures, while simultaneously supporting normal physiology, would be associated with measurable clinical improvement.

This shift transformed the consultation from a discussion about treatment into an investigation of the patient’s personal exposome—the cumulative environmental influences encountered throughout life.

Environmental Investigation

A structured environmental exposure history identified numerous potential sources of chronic microplastic exposure.

• Potential dietary sources included municipal drinking water, bottled water consumed regularly, a morning take-out cup of coffee, food stored or reheated in plastic containers, take-out packaging, and foods packaged in plastic materials.
• Household and workplace exposures included synthetic carpeting, upholstered furniture, indoor dust, synthetic clothing, laundering of polyester textiles, automobile interiors, and prolonged conference-related travel.
• Personal care products represented another potentially important source. Shampoo, conditioner, cosmetics, sunscreen, toothbrush, toothpaste, and other hygiene products were reviewed for ingredients containing synthetic polymers or plastic-derived compounds. 
• Outdoor exposures include highway tire dust, commercial and industrial areas, and other airborne contaminants both local, regional, and even international via the jet stream.

Individually, none of these exposures appeared remarkable. Collectively, however, they reflected the reality experienced by many patients living in industrialized societies—continuous low-level exposure through multiple pathways.

This investigation reinforced an important clinical lesson: patients who appear exceptionally health conscious may still experience substantial cumulative environmental exposure simply because many sources are woven into modern daily life.

Clinical Context

The patient’s history of inflammatory bowel disease added another important dimension to the case.

IBD is characterized by chronic intestinal inflammation, immune dysregulation, and impaired epithelial barrier function. Although it cannot be concluded that impaired barrier integrity increased systemic uptake of microplastics in this patient, gastrointestinal dysfunction provided a biologically plausible rationale for addressing intestinal health as part of the overall management strategy.

Rather than viewing the gastrointestinal disease and environmental exposure history as unrelated, they were considered complementary components, such as comorbidities, of a systems-based clinical assessment.

Comprehensive Clinical Intervention

The intervention was intentionally designed around four integrated principles.

1. Mitigate Environmental Exposure

The initial priority was reducing avoidable environmental exposure wherever practical.

The patient installed reverse-osmosis drinking water filtration, eliminated plastic drinking bottles, replaced plastic food-storage containers with glass and stainless steel, reduced plastic food packaging, introduced HEPA air filtration within the home, increased use of natural-fiber clothing and household textiles, and transitioned toward personal care products free of unnecessary synthetic polymers whenever feasible.

The objective was not complete elimination of environmental exposure—an unrealistic expectation—but meaningful reduction of cumulative exposure over time.

2. Restore Gastrointestinal Integrity

Recognizing the importance of gastrointestinal physiology, the patient continued an individualized nutritional program designed to support intestinal barrier function, microbial diversity, and normal digestive physiology.

The program included a whole-food dietary pattern together with multi-strain probiotics, bovine colostrum, dietary fiber, omega-3 fatty acids, Coenzyme Q10, and a broad-spectrum micronutrient formulation selected to address nutritional sufficiency and physiological resilience.

3. Support Endogenous Physiological Resilience

Rather than promoting a “detoxification” protocol, the clinical strategy emphasized support of normal endogenous physiology.

Nutritional cofactors, antioxidant-rich foods, mitochondrial support, hydration, regular bowel function, and dietary measures that support hepatic metabolism were incorporated to promote the body’s intrinsic biotransformation and elimination processes, commonly described clinically as Phase I, Phase II, and Phase III detoxification pathways.

Importantly, these interventions were intended to optimize normal physiological function rather than imply that any individual supplement directly removes microplastic particles from the body.

4. Measure the Response

Objective reassessment formed the final component of the clinical strategy.

Although symptom improvement remains clinically meaningful, repeat testing allows clinicians to evaluate whether patient-reported changes are accompanied by measurable biological changes.

Approximately six months after implementation of the integrated environmental and physiological support program, repeat salivary microplastic analysis was performed using the same testing methodology.

Table 1. Verified Salivary Microplastic Particle Counts Before and After Comprehensive Environmental Mitigation

Table Legend: Comparison of verified salivary microplastic particle counts obtained before (December 2025) and after (June 2026) implementation of a comprehensive environmental mitigation and integrative physiological support program. Findings represent observations from a single patient and should be interpreted as hypothesis-generating rather than evidence of causality.

Interpretation of the Verified Findings

Repeat testing demonstrated a reduction in the total measured salivary microplastic particle count from 29 particles at baseline to 12 particles at follow-up, representing an approximate 59% reduction. The greatest reduction occurred within the 10–30 µm particle fraction, while 30–70 µm particles were no longer detected at follow-up. The <10 µm fraction remained unchanged, suggesting that the observed changes were not uniform across particle sizes.

These objective laboratory findings paralleled meaningful improvements reported by the patient, including fewer inflammatory bowel disease flares, improved gastrointestinal comfort, greater energy, enhanced cognitive clarity, and an overall improvement in quality of life.

Because exposure mitigation, nutritional optimization, gastrointestinal support, and lifestyle interventions were introduced concurrently, no single component can reasonably be identified as responsible for the observed changes. Instead, this case illustrates the potential value of a comprehensive, systems-based approach in which environmental exposure reduction is combined with restoration of gastrointestinal integrity, support of endogenous physiological resilience, and objective follow-up testing. The findings should therefore be interpreted as an association that warrants further investigation rather than as evidence establishing cause and effect.

Discussion

This case illustrates a practical approach to environmental medicine rather than evidence for a single therapeutic intervention. A health-conscious patient with inflammatory bowel disease and an unexpectedly elevated salivary microplastic burden underwent a comprehensive strategy that combined environmental exposure mitigation, restoration of gastrointestinal physiology, nutritional optimization, and support of endogenous physiological resilience. Six months later, repeat testing demonstrated a reduction in measured salivary microplastic particle counts together with meaningful improvements in gastrointestinal symptoms, energy, cognitive clarity, and overall well-being.

The observations are clinically interesting for several reasons.

First, they emphasize the importance of objective assessment. Environmental exposures are often underestimated because they are embedded within ordinary aspects of daily life, including drinking water, food packaging, indoor air, household dust, synthetic textiles, and personal care products. A structured environmental history may reveal numerous low-level exposures that individually appear insignificant but collectively contribute to the patient’s overall exposome.

Second, this case highlights the importance of physiological context. Patients with chronic inflammatory disorders, including inflammatory bowel disease, may warrant broader environmental assessment because gastrointestinal barrier dysfunction, immune dysregulation, and chronic inflammation could plausibly influence interactions between environmental contaminants and host physiology. Although current evidence does not establish that impaired barrier integrity increases systemic microplastic absorption in individual patients, addressing gastrointestinal health remains a rational component of comprehensive care.

Third, the patient’s improvement followed implementation of a multifaceted intervention, not a single treatment. Exposure reduction occurred simultaneously with nutritional optimization, gastrointestinal support, lifestyle modification, and physiological support. Consequently, it is neither possible nor appropriate to attribute the observed changes to any individual intervention. Instead, the findings support a systems-based approach in which multiple modifiable factors are addressed concurrently.

Equally important are the limitations.

This report describes a single patient and therefore cannot establish causality or generalizability. Salivary microplastic testing remains an emerging methodology, and standardized reference ranges, inter-laboratory reproducibility, and long-term clinical significance continue to evolve. Furthermore, environmental exposures fluctuate over time, and the measured reductions observed in this patient may have been influenced by variables that were not fully captured. 

Nevertheless, the case offers a practical lesson. Rather than asking whether microplastics alone caused disease, clinicians may find greater value in asking whether reducing avoidable environmental exposures while restoring normal physiology can contribute to improved patient outcomes. That question is clinically actionable, scientifically responsible, and worthy of further investigation.

Clinical Pearls

1. Test thoughtfully.

Objective assessment should complement—not replace—a comprehensive history and physical examination. Environmental testing is most valuable when results have the potential to influence clinical decision-making.

2. Think in terms of the exposome.

Patients rarely encounter a single environmental exposure. Instead, they experience cumulative interactions among diet, water, air, household products, occupational factors, and lifestyle. Start with just one action so it’s simple for the patient to get started.  Add another every week. 

3. Mitigate before adding complexity.

Reducing avoidable environmental exposures should be considered before relying exclusively on nutritional supplementation or other therapeutic interventions.

4. Restore normal physiology.

Support gastrointestinal barrier integrity, microbial diversity, nutritional sufficiency, sleep, physical activity, hydration, and endogenous biotransformation pathways as part of a comprehensive systems-based approach.

5. Measure again.

Whenever practical, repeat objective testing using the same methodology to evaluate whether meaningful changes accompany patient-reported clinical improvement.

Clinical Framework

Test → Mitigate → Restore → Support → Measure

Test: Use objective assessment when clinically appropriate and when results may influence management.

Mitigate: Identify and reduce avoidable environmental exposures through practical, sustainable interventions.

Restore: Optimize gastrointestinal integrity, microbiome function, and nutritional status.

Support: Promote endogenous physiological resilience through evidence-informed diet, lifestyle, and targeted nutritional support.

Measure: Reassess objective biomarkers and patient-reported outcomes to evaluate progress over time.

Conclusion

Microplastics represent one component of the modern human exposome, and their long-term clinical significance continues to be defined. While this case does not establish that microplastic exposure caused disease or that reducing measured particle burden directly produced clinical improvement, it demonstrates the value of a structured clinical approach grounded in objective assessment, environmental investigation, exposure mitigation, restoration of physiological function, and longitudinal follow-up.

Perhaps the most enduring lesson is not about microplastics themselves, but about clinical reasoning. Rather than relying on assumptions, clinicians can investigate thoughtfully, identify modifiable contributors to health, support the body’s intrinsic physiological resilience, and objectively evaluate outcomes.

In an increasingly complex environmental world, the guiding principle remains both practical and timeless:

Test. Mitigate. Restore. Support. Measure.

References

Leslie, HA, van Velzen, MJM, Brandsma, SH, Vethaak, AD, Garcia-Vallejo, JJ, and Lamoree, MH. (2022) Discovery and quantification of plastic particle pollution in human blood, Environment International, 163, 107199.

Marfella, R. et al. (2024) Microplastics and nanoplastics in carotid artery plaque and cardiovascular events, New England Journal of Medicine, 390, pp. 900–910.

Roslan, NS. et al. (2024) Detection of microplastics in human tissues and organs: A scoping review, Journal of Global Health Reports, 8.

World Health Organization (2022) Dietary and Inhalation Exposure to Nano- and Microplastic Particles and Potential Implications for Human Health. Geneva: World Health Organization.

Yan, Z, Liu, Y, Zhang, T, Zhang, F, Ren, H, and Zhang, Y. (2022) Analysis of microplastics in human feces reveals a correlation between fecal microplastics and inflammatory bowel disease status, Environmental Science and Technology, 56(1), pp. 414–421.